Cerdulatinib (PRT2070)
CAS: 1198300-79-6
Ref. 3D-YXB30079
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Product Information
Cerdulatinib (PRT2070) is an ester hydrochloride compound with antifibrotic properties. It has been shown to inhibit the growth and proliferation of fibroblasts, which play a key role in the development of fibrosis. Cerdulatinib works by targeting alpha-tocotrienol, nintedanib, sildenafil, and other nucleophilic compounds involved in fibrotic pathways. Additionally, it has been found to inhibit fatty acid synthesis and collagen production, further contributing to its anti-fibrotic effects. Research suggests that cerdulatinib may also modulate the activity of β-catenin, a protein involved in cell signaling pathways related to fibrosis. This compound shows promise as a potential therapeutic option for various fibrotic conditions.
Chemical properties
Technical inquiry about: 3D-YXB30079 Cerdulatinib (PRT2070)
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
